Of $579.9 million awarded to Baltimore in opioid settlements, $392.5 million has been received by the city, with nearly 40% ...
BUFFALO, N.Y. — Joshua Lynch, DO, professor of emergency medicine in the Jacobs School of Medicine and Biomedical Sciences at ...
ABC 7 New York on MSN
Sherrill doubles down on claim that Ciattarelli profited from opioid crisis
Democrat Mikie Sherrill is refusing to back down from her claims that Republican Jack Ciattarelli was 'complicit' with opioid ...
PARSIPPANY, New Jersey (WABC) -- The nation's addiction to opioids is part of a crisis plaguing communities across America and particularly the Tri-State Area. According to the National Institute on ...
Forty-three percent of Americans say the prescription drug abuse is a serious issue, up 10 percent from 2016, according to a survey by The Associated Press-NORC Center for Public Affairs Research. The ...
Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse Statistics. New ...
Representative Mikie Sherrill, a New Jersey Democrat, said a firm once owned by her Republican opponent, Jack Ciattarelli, ...
Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...
PARSIPPANY, New Jersey -- The nation's addiction to opioids is part of a crisis plaguing communities across America and particularly the Tri-State Area. According to the National Institute on Drug ...
Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...
Opioid analgesics represent one of our earliest and most effective therapeutic classes of medication. Despite their recognized efficacy, the opioids have historically been subjected to periods of ...
September 26, 2011 (Las Vegas, Nevada) — A novel opioid drug candidate being developed to reduce the likelihood of abuse has shown safety, tolerability, and significant bioavailability in a phase 1 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果